These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 13378581)
21. [Skeletal metastases of carcinoma of the breast]. VENTURI R Chir Organi Mov; 1960; 49():399-427. PubMed ID: 13780739 [No Abstract] [Full Text] [Related]
22. The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease. Pecherstorfer M; Zimmer-Roth I; Schilling T; Woitge HW; Schmidt H; Baumgartner G; Thiébaud D; Ludwig H; Seibel MJ J Clin Endocrinol Metab; 1995 Jan; 80(1):97-103. PubMed ID: 7829646 [TBL] [Abstract][Full Text] [Related]
23. Sensitivity of 18 F bone scans in the search for metastases. Sharma SM; Quinn JL Surg Gynecol Obstet; 1972 Oct; 135(4):536-40. PubMed ID: 5085991 [No Abstract] [Full Text] [Related]
24. Breast carcinoma with lung and bone metastases treated with laetrile; case report. NAVARRO MD; LAGMAN CL J Philipp Med Assoc; 1957 Jan; 33(1):16-20. PubMed ID: 13417107 [No Abstract] [Full Text] [Related]
25. Biochemical picture of bone metabolism in breast cancer patients with bone metastases. Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881 [TBL] [Abstract][Full Text] [Related]
26. [Double-blind trial of oral clodronate in breast cancer patients with bone metastases]. Paterson AH; Powles TJ; Kanis JA; McCloskey E; Hanson J; Ashley S Bull Cancer; 1993; 80(10 Suppl):50-6. PubMed ID: 8081032 [No Abstract] [Full Text] [Related]
27. [Determination of calcitonin and parathyrin in blood serum in the diagnosis of tumor metastases to bone]. Smirnov IuN Med Radiol (Mosk); 1986 Apr; 31(4):9-12. PubMed ID: 3959820 [TBL] [Abstract][Full Text] [Related]
28. [The value of laboratory examinations in diagnosis of metastases in breast carcinoma]. Otto K Med Welt; 1967 Sep; 36():2122-6. PubMed ID: 5614249 [No Abstract] [Full Text] [Related]
29. [The effect of chemotherapy on bone metabolism in patients with non-small cell lung cancer]. Kołaczkowska M; Junik R; Rzymkowska M; Kramer L Pneumonol Alergol Pol; 1998; 66(5-6):283-9. PubMed ID: 9857648 [TBL] [Abstract][Full Text] [Related]
30. Skeletal effects of carcinoma of the breast and prostate. Percival RC Ann R Coll Surg Engl; 1986 Sep; 68(5):267-70. PubMed ID: 3789624 [TBL] [Abstract][Full Text] [Related]
31. A study of urinary excretion of parathyroid hormone in man. Bethune JE; Turpin RA J Clin Invest; 1968 Jul; 47(7):1583-9. PubMed ID: 5658589 [TBL] [Abstract][Full Text] [Related]
32. Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases. Ratasvuori M; Wedin R; Hansen BH; Keller J; Trovik C; Zaikova O; Bergh P; Kalen A; Laitinen M J Surg Oncol; 2014 Sep; 110(4):360-5. PubMed ID: 24889389 [TBL] [Abstract][Full Text] [Related]
33. [Variable behavior of urinary hydroxyproline in breast cancer with osseous metastases]. Polico C; Nascimben O; Maccari F; Fazzin G Quad Sclavo Diagn; 1978 Dec; 14(4):486-93. PubMed ID: 757622 [TBL] [Abstract][Full Text] [Related]
34. Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. Hebert LA; Lemann J; Petersen JR; Lennon EJ J Clin Invest; 1966 Dec; 45(12):1886-94. PubMed ID: 5953818 [No Abstract] [Full Text] [Related]
35. The role of PET/CT in the evaluation of skeletal metastases. Kannivelu A; Loke KS; Kok TY; Osmany SY; Ali SZ; Suat-Jin L; Ng DC Semin Musculoskelet Radiol; 2014 Apr; 18(2):149-65. PubMed ID: 24715447 [TBL] [Abstract][Full Text] [Related]
36. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms. Radom S; Zulawski M; Golebiowska D Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776 [No Abstract] [Full Text] [Related]
37. [Kinetics of calcium metabolism in malignant bone neoplasms]. Sack H Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:70-1. PubMed ID: 4341237 [No Abstract] [Full Text] [Related]